How a Director’s Stock Sale and MMAE Optimism At Penumbra (PEN) Has Changed Its Investment Story

On January 6, 2026, a Penumbra director reported selling 186 shares, while a recent analyst report highlighted growing ...

Assessing Penumbra (PEN) Valuation After Analyst Optimism And Strong Third Quarter Guidance

What triggered fresh attention on Penumbra Recent analyst optimism around Penumbra (PEN), centered on its middle meningeal ...
Seeking Alpha

Johnson & Johnson Receives FDA Approval for TRUFILL n‑BCA Liquid Embolic System for the Treatment of Symptomatic Chronic Subdural Hematoma

- TRUFILL n-BCA is now indicated for embolization of the middle meningeal artery (MMA) for the treatment of symptomatic subacute and Chronic Subdural Hematoma (cSDH) as an adjunct to surgery. - ...
Nature

Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
Nasdaq

FDA Approves Expanded Use Of Johnson & Johnson's TRUFILL N-BCA For Subdural Hematoma

(RTTNews) - Johnson & Johnson MedTech, the medical technology arm of Johnson & Johnson (J&J) on Thursday said the U.S. Food and Drug Administration (FDA) has approved an expanded indication for its ...